Bank of Nova Scotia’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-125
Closed -$134K 1160
2025
Q4
$134K Sell
125
-529
-81% -$506K ﹤0.01% 1053
2025
Q3
$499K Buy
+654
New +$487K ﹤0.01% 884

Other funds holding LLY

Bank of Nova Scotia's LLY Position: Q1 2026 in Review

Bank of Nova Scotia increased its Eli Lilly (LLY) stake by 4.6% in Q1 2026, buying an estimated $16.1M and bringing the position to 360,137 shares worth $331M. The position accounts for 0.58% of the portfolio, ranked #27.

Bank of Nova Scotia first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $370M in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bank of Nova Scotia held 360,137 shares of Eli Lilly worth $331M as of Q1 2026.
  • Bank of Nova Scotia bought 15,854 Eli Lilly shares in Q1 2026, an estimated $16.1M.
  • Eli Lilly made up 0.58% of Bank of Nova Scotia's portfolio in Q1 2026, its #27 holding.
  • Bank of Nova Scotia first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Bank of Nova Scotia's Eli Lilly position peaked at $370M in Q4 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.